Article
RHCE*ceMO is frequently in cis to RHD*DAU0 and encodes a hr(S) -, hr(B) -, RH:-61 phenotype in black persons: clinical significance. Westhoff CM, Vege S, Horn T, Hue-Roye K, Halter Hipsky C, Lomas-Francis C, Reid ME. Transfusion, 2013. [Citation]
Annotations by Allele
- DOL - partly characterized or subtypes not separated: RH
- DOL - partly characterized or subtypes not separated: Prevalence
- RHD*1136T (DAU0): AbSpecificity
- RHD*1136T (DAU0): Prevalence
- RHD*1136T (DAU0): Prevalence
- RHD*1136T (DAU0): Prevalence
- RHD*1136T (DAU0): Prevalence
- RHD*1136T (DAU0): RH1
- RHD*1136T (DAU0): RH
- RHD*1136T (DAU0): RH
- RHD*1154C (weak D type 2): RH
- RHD*1154C (weak D type 2): RH
- RHD*1154C (weak D type 2): Prevalence
- RHD*186T,410T,455C,1048C (DIVa): Prevalence
- RHD*602G,667G,744T,1025C (weak D type 4.2.3, DAR1.03): Prevalence
- RHD*602G,667G,744T,1025C (weak D type 4.2.3, DAR1.03): RH
- RHD*602G,667G,744T,957A,1025C (weak D type 4.2.2, DAR1.02): RH
- RHD*602G,667G,744T,957A,1025C (weak D type 4.2.2, DAR1.02): Prevalence
- RHD*835A,1136T (DAU3): Prevalence
- RHD*D-CE(7-10): RH
- RHD*D-CE(7-10): otherHaplotype
- RHD*D-CE(7-10): Prevalence
- RHD*DIIIa-CEVS(4-7)-D (RHD*03N.01): Prevalence
- RHD*DIIIa-CEVS(4-7)-D (RHD*03N.01): Prevalence
- RHD*DIIIa-CEVS(4-7)-D (RHD*03N.01): RH
- RHD*DIIIa-CEVS(4-7)-D (RHD*03N.01): RH
- RHD*DIIIa-CEVS(4-7)-D (RHD*03N.01): AbSpecificity
- standard RHD (RHD*01): RH
- standard RHD (RHD*01): RH
- standard RHD (RHD*01): AbSpecificity
- standard RHD (RHD*01): Prevalence
- standard RHD (RHD*01): Prevalence